OLOPATADINE 0.1%w/v IP

A topical ophthalmic anti-allergy agent that is effective at alleviating symptoms of allergic diseases. (Kenji Ohmori, 2004) An antihistamine eye solution that resolves the signs and symptoms of allergic conjunctivitis, notably, itching, redness, tearing, lid swelling, and chemosis. (Bobby Q Lanier, 2004) Controls ocular and nasal symptoms of allergic conjunctivitis and rhinoconjunctivitis. (Mark B Abelson, 2003) Superior to the other anti-allergic molecules due to its strong anti-histaminic and ocular mast cell stabilizing qualities. (Lanny J Rosenwasser, 2005) Significantly improves ocular allergic symptoms and overall patients’ quality of life. (William Berger, 2005) More efficacious than loratadine 10 mg tablets in reducing ocular itching related to allergic conjunctivitis. (M B Abelson, 2000) Reduces ocular itching significantly more than ketorolac in the seasonal allergic conjunctivitis population. (Volkan Yaylali, 2003) Provides quicker relief of symptoms and signs in subjects with allergic conjunctivitis than ketotifen fumarate 0.025%. (Dharmistha Patel, 2018) A viable alternative or addition to first-line therapies such as intranasal steroids and oral antihistamines. (Alexei Gonzalez-Estrada, 2017)